ArticleThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry2019
Systems Delivery Innovation for Alzheimer Disease.
Article in The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Prevalence of Low-Value Care and Its Associations with Patient-Centered Outcomes in Dementia.Journal of Alzheimer's disease : JAD · 2021Trial
- A culturally tailored iSupport model for dementia carers: Study protocol for a hybrid type I randomised controlled trial.International journal of nursing studies advances · 2026Article
- An Ultra-Brief Informant Questionnaire for Case Finding of Cognitive Impairment Across Diverse Literacy: Diagnostic Accuracy Study.JMIR aging · 2026Article
- PENSIEVE-AI a brief cognitive test to detect cognitive impairment across diverse literacy.Nature communications · 2025Article
- Entrepreneurship in care for elderly people with dementias: situated responses to NPM-based healthcare reforms in the Netherlands.BMC health services research · 2023Article
- Exploring the role of a facilitator in supporting family carers when embedding the iSupport for Dementia programme in care services: A qualitative study.Journal of clinical nursing · 2023Article
- Catalyzing dementia care through the learning health system and consumer health information technology.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023Article
- The role of care partners in medical visits of older adults with hearing loss and dementia: A national study.Journal of the American Geriatrics Society · 2023Article
- Six domains of health: a practical approach to identifying priorities in dementia care.Frontiers in dementia · 2023Article
- Creating 'Partnership in iSupport program' to optimise family carers' impact on dementia care: a randomised controlled trial protocol.BMC health services research · 2022Article
- Experience of the healthcare system for caregivers of persons with dementia.Aging and health research · 2022Article
- Life satisfaction among older adults with impairment in activities of daily living.Age and ageing · 2021Article
- In-Home Video Telehealth for Dementia Management: Implications for Rehabilitation.Current geriatrics reports · 2019Article
- Health Care Is Failing the Most Vulnerable Patients: Three Underused Solutions.Public health reports (Washington, D.C. : 1974)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveThe authors describe a comprehensive care model for Alzheimer disease (AD) that improves value within 1-3 years after implementation by leveraging targeted outpatient chronic care management, cognitively protective acute care, and timely caregiver support.
methodsUsing current best evidence, expert opinion, and macroeconomic modeling, the authors designed a comprehensive care model for AD that improves the quality of care while reducing total per capita healthcare spending by more than 15%. Cost savings were measured as reduced spending by payers. Cost estimates were derived from medical literature and national databases, including both public and private U.S. payers. All estimates reflect the value in 2015 dollars using a consumer price index inflation calculator. Outcome estimates were determined at year 2, accounting for implementation and steady-state intervention costs.
resultsAfter accounting for implementation and recurring operating costs of approximately $9.5 billion, estimated net cost savings of between $13 and $41 billion can be accomplished concurrently with improvements in quality and experience of coordinated chronic care ($0.01-$6.8 billion), cognitively protective acute care ($8.7-$26.6 billion), timely caregiver support ($4.3-$7.5 billion), and caregiver efficiency ($4.1-$7.2 billion).
conclusionA high-value care model for AD may improve the experience of patients with AD while significantly lowering costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.